What Does it Mean?

A $125,000 machine from Knome aims to take the pain out of genome analysis. As The New York Times reports, the cost of sequencing a human genome is dropping, though analysis is still an issue and the machine, called the knoSYSTM100, may help researchers interpret what those sequences mean. For an extra $25,000 a year, users can get software updates and technical support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."